Lumen Technologies, Inc.

For the period ended Sep 30, 2026. Filed Nov 4, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 4, 2026

LUMN$4.71+9.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets (Unaudited)

CONSOLIDATED BALANCE SHEETS

	September 30, 2026	December 31, 2025
(Dollars in millions and shares in thousands)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$978	1,003
Accounts receivable, net of allowance of $39 and $67	1,400	1,314
Assets held for sale	9	4,285
Other current assets, net	817	1,307
Total current assets	3,204	7,909
Property, plant and equipment, net of accumulated depreciation of $24,547 and $23,744	20,857	19,575
GOODWILL AND OTHER ASSETS
Goodwill	268	—
Intangible assets, net	4,110	4,463
Other assets, net	2,285	2,395
Total goodwill and other assets	6,663	6,858
TOTAL ASSETS	$30,724	34,342
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Current maturities of long-term debt	$29	88
Accounts payable	1,302	1,508
Accrued expenses and other liabilities
Salaries and benefits	791	854
Income and other taxes	700	279
Current operating lease liabilities	282	266
Interest	123	149
Other current liabilities	293	203
Liabilities held for sale	2	38
Current portion of deferred revenue	1,020	1,005
Total current liabilities	4,542	4,390
LONG-TERM DEBT	13,164	17,353
DEFERRED CREDITS AND OTHER LIABILITIES
Deferred income taxes, net	1,671	2,270
Benefit plan obligations, net	1,904	2,103
Deferred revenue	8,238	6,406
Other liabilities	2,927	2,937
Total deferred credits and other liabilities	14,740	13,716
COMMITMENTS AND CONTINGENCIES (Note 11)
STOCKHOLDERS' DEFICIT
Preferred stock—non-redeemable, $25.00 par value, authorized 2,000 and 2,000 shares, issued and outstanding 7 and 7 shares	—	—
Common stock, no par value, authorized 2,200,000 and 2,200,000 shares, issued and outstanding 1,031,172 and 1,025,446 shares	19,196	19,185
Accumulated other comprehensive loss	(551)	(601)
Accumulated deficit	(20,367)	(19,701)
Total stockholders' deficit	(1,722)	(1,117)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$30,724	34,342

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.